MENU
+Compare
GMRE
Stock ticker: NYSE
AS OF
Jul 3 closing price
Price
$7.27
Change
+$0.12 (+1.68%)
Capitalization
573.78M

GMRE Global Medical REIT Forecast, Technical & Fundamental Analysis

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems... Show more

GMRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GMRE with price predictions
Jul 03, 2025

GMRE in upward trend: 10-day moving average broke above 50-day moving average on July 03, 2025

The 10-day moving average for GMRE crossed bullishly above the 50-day moving average on July 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 18, 2025. You may want to consider a long position or call options on GMRE as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GMRE just turned positive on June 03, 2025. Looking at past instances where GMRE's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

GMRE moved above its 50-day moving average on June 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GMRE advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 229 cases where GMRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GMRE broke above its upper Bollinger Band on June 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GMRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.114) is normal, around the industry mean (1.997). P/E Ratio (37.565) is within average values for comparable stocks, (63.028). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.654). Dividend Yield (0.097) settles around the average of (0.070) among similar stocks. P/S Ratio (4.019) is also within normal values, averaging (7.058).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
GMRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GMRE is expected to report earnings to fall 66.67% to 0 cents per share on July 30

Global Medical REIT GMRE Stock Earnings Reports
Q2'25
Est.
$0.01
Q1'25
Beat
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.04
Q1'24
Est.
$0.01
The last earnings report on May 07 showed earnings per share of 2 cents, beating the estimate of 0 cents. With 436.82K shares outstanding, the current market capitalization sits at 573.78M.
A.I.Advisor
published Dividends

GMRE is expected to pay dividends on July 09, 2025

Global Medical REIT GMRE Stock Dividends
A dividend of $0.15 per share will be paid with a record date of July 09, 2025, and an ex-dividend date of June 20, 2025. The last dividend of $0.21 was paid on April 09. Read more...
A.I. Advisor
published General Information

General Information

a company, which engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups

Industry RealEstateInvestmentTrusts

Profile
Fundamentals
Details
Industry
Real Estate Investment Trusts
Address
7373 Wisconsin Avenue
Phone
+1 202 524-6851
Employees
26
Web
https://www.globalmedicalreit.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASDX17.53N/A
N/A
Fidelity Advisor Strategic Div & Inc A
TGVYX56.62N/A
N/A
Touchstone Dynamic Large Cap Growth Y
HRLVX22.84N/A
N/A
Harbor Large Cap Value Admin
QISGX28.53N/A
N/A
Federated Hermes MDT Small Cap Growth IS
SROIX13.26N/A
N/A
Calamos Antetokounmpo Sustainable Eqs I

GMRE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GMRE has been loosely correlated with OLP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GMRE jumps, then OLP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMRE
1D Price
Change %
GMRE100%
+1.68%
OLP - GMRE
62%
Loosely correlated
+0.99%
UDR - GMRE
62%
Loosely correlated
+0.57%
STAG - GMRE
62%
Loosely correlated
-0.05%
PLYM - GMRE
62%
Loosely correlated
+0.68%
IRT - GMRE
61%
Loosely correlated
+0.85%
More